Aria Diagnostics Obtains $52,700,000 Series C Financing

  • Feed Type
  • Date
    1/10/2012
  • Company Name
    Aria Diagnostics
  • Mailing Address
    5945 Optical Court San Jose, CA 95138
  • Company Description
    Aria Diagnostics is a privately funded biotechnology company based on a strong scientific foundation. Our novel blood tests equip pregnant women with the right information to make decisions regarding the health of their baby and their own body.
  • Website
    http://www.ariadx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $52,700,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Aria will use the funds to support product development and prepare commercialization of its proprietary prenatal test to detect common fetal trisomies such as Trisomy 21, which is associated with Down syndrome.
  • M&A Terms
  • Venture Investor
    Meritech Capital Partners
  • Venture Investor
    Venrock
  • Venture Investor
    Domain Associates

By posting a comment, you agree to our terms and conditions.